BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
作者信息
Chen Lingdan, Liu Chunli, Lu Wenju, Wang Tao
机构信息
The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, China.
出版信息
Am J Respir Crit Care Med. 2020 May 15;201(10):1313. doi: 10.1164/rccm.201912-2525LE.
Abstract
摘要
相似文献
1
BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?溴结构域和额外末端结构域（BET）信号传导：肺动脉高压的新型治疗靶点？
Am J Respir Crit Care Med. 2020 May 15;201(10):1313. doi: 10.1164/rccm.201912-2525LE.
2
Reply to Chen : BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?对陈的回复：BET信号传导：肺动脉高压的新型治疗靶点？
Am J Respir Crit Care Med. 2020 May 15;201(10):1313-1314. doi: 10.1164/rccm.202001-0059LE.
3
EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.EpiHope用于治疗肺动脉高压：选择性与非选择性BET抑制作用
Am J Respir Crit Care Med. 2019 Nov 1;200(9):1188-1190. doi: 10.1164/rccm.201906-1235LE.
4
Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension.
Cardiovasc Res. 2019 Jul 1;115(8):1260-1261. doi: 10.1093/cvr/cvz071.
5
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?多组学：通往理解肺动脉高压之路的下一步？
Thorax. 2019 Apr;74(4):317-318. doi: 10.1136/thoraxjnl-2018-212840. Epub 2019 Jan 24.
6
Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.剖析肺动脉高压中的大熔炉现象
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1329-1331. doi: 10.1164/rccm.202001-0156ED.
7
A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.一种用于肺动脉高压免疫调节的新型肽。
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1460-1461. doi: 10.1164/rccm.201902-0388ED.
8
Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.关卡激酶1促进肺动脉高压的发展。
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
9
"Rehab for all!" Is it too early in pulmonary arterial hypertension?“全民康复！”对于肺动脉高压而言，现在提这个是否为时过早？
Eur Respir J. 2019 Nov 7;54(5). doi: 10.1183/13993003.01558-2019. Print 2019 Nov.
10
Real-World Data for Pulmonary Arterial Hypertension.肺动脉高压的真实世界数据。
Chest. 2019 Apr;155(4):653-654. doi: 10.1016/j.chest.2019.01.031.
引用本文的文献
1
circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?环状GSAP：特发性肺动脉高压的一种新的临床生物标志物？
Am J Respir Crit Care Med. 2022 Jan 15;205(2):252-253. doi: 10.1164/rccm.202108-1868LE.
本文引用的文献
1
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.多中心临床前验证 BET 抑制剂治疗肺动脉高压。
Am J Respir Crit Care Med. 2019 Oct 1;200(7):910-920. doi: 10.1164/rccm.201812-2275OC.
2
Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.肺动脉高压的靶向治疗：2018 年科隆共识会议的更新建议。
Int J Cardiol. 2018 Dec 1;272S:37-45. doi: 10.1016/j.ijcard.2018.08.082. Epub 2018 Aug 25.
3
2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.2015年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002.
Zotero 插件